Showing 1 - 7 results of 7 for search 'Christopher Fletcher', query time: 0.02s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Phase II study of venetoclax added to bendamustine and obinutuzumab in patients with high-risk follicular lymphoma as front-line therapy: PrE0403 by Craig A. Portell, Opeyemi A. Jegede, Nina Wagner-Johnston, Grzegorz S. Nowakowski, Christopher Fletcher, Jonathon B. Cohen, Andrew M. Evens, Lori J. Rosenstein, Jeffrey W. Craig, Nishitha Reddy, Brad S. Kahl
Published 2025-05-01Get full text
Article